跳至主要内容
临床试验/NCT05601258
NCT05601258已完成不适用

Association Between Pancreatic Lipase Levels and Coronavirus Disease 2019

Uşak University1 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2020年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,000
试验地点
1
主要终点
The frequency of lipase enzyme elevation will be compared

研究概览

简要总结

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.

In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

接受健康志愿者

入选标准

  • Patients with lipase levels measured during COVID-19

排除标准

  • Patients with age <18 years Patients with pregnancy Patients whose lipase levels were not measured in the course of COVID-19 Patients with known solid organ malignacy Patients with known hematologic malignacy

结局指标

主要结局

The frequency of lipase enzyme elevation will be compared

时间窗: From 31th March 2020 until 9th July 2021

The mortaliy rate will be compared

时间窗: From 31th March 2020 until 9th July 2021

次要结局

未报告次要终点

研究者

发起方
Uşak University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cevdet Duran

Cevdet Duran

Uşak University

研究点 (1)

Loading locations...

相似试验